1. Home
  2. ATLO vs TLSI Comparison

ATLO vs TLSI Comparison

Compare ATLO & TLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ames National Corporation

ATLO

Ames National Corporation

HOLD

Current Price

$23.50

Market Cap

186.3M

Sector

Finance

ML Signal

HOLD

Logo TriSalus Life Sciences Inc.

TLSI

TriSalus Life Sciences Inc.

HOLD

Current Price

$7.19

Market Cap

244.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATLO
TLSI
Founded
1903
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
186.3M
244.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ATLO
TLSI
Price
$23.50
$7.19
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$11.50
AVG Volume (30 Days)
25.9K
183.2K
Earning Date
01-23-2026
11-13-2025
Dividend Yield
3.37%
N/A
EPS Growth
82.57
N/A
EPS
1.80
N/A
Revenue
$60,568,000.00
$40,207,000.00
Revenue This Year
N/A
$55.06
Revenue Next Year
N/A
$46.04
P/E Ratio
$13.22
N/A
Revenue Growth
18.60
49.52
52 Week Low
$15.75
$3.42
52 Week High
$24.36
$7.70

Technical Indicators

Market Signals
Indicator
ATLO
TLSI
Relative Strength Index (RSI) 68.26 65.09
Support Level $23.60 $6.96
Resistance Level $24.12 $7.53
Average True Range (ATR) 0.47 0.50
MACD 0.07 -0.02
Stochastic Oscillator 67.93 68.69

Price Performance

Historical Comparison
ATLO
TLSI

About ATLO Ames National Corporation

Ames National Corporation is a United States-based bank holding company. It provides short-term and medium-term commercial, multi-family, and agricultural real estate loans, residential real estate loans, agricultural and business operating loans and lines of credit, equipment loans, vehicle loans, personal loans and lines of credit, home improvement loans and origination of mortgage loans for sale into the secondary market. The Banks also offer a variety of checking, savings and time deposits, cash management services, merchant credit card processing, safe deposit boxes, wire transfers, direct deposit and automated/video teller machine access. The banking segment generates revenues through personal, business, agricultural and commercial lending, and Others.

About TLSI TriSalus Life Sciences Inc.

TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.

Share on Social Networks: